HTLV-I transgenic models: An overview

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Ozden, Simona ^a   Coscoy, Laurent ^a   Gonzalez Dunia, Daniel ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Arthropathy; Human T cell leukemia virus type I long terminal repeat; Neurofibromas; Sialadenitis; Tax; Transgenic models

Indexed keywords

TAX PROTEIN;

ANIMAL MODEL; ARTHROPATHY; CONFERENCE PAPER; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LONG TERMINAL REPEAT; MOUSE; NEUROFIBROMA; NONHUMAN; PRIORITY JOURNAL; SIALOADENITIS; SPASTIC PARESIS; T CELL LEUKEMIA; TRANSGENIC MOUSE; VIRUS EXPRESSION;

ANIMALIA; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; MUS MUSCULUS;

EID: 0029759243     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199600001-00024     Document Type: Conference Paper

References (49)

1. Gessain A, Barin E, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985;2:407-10.
2. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986;1:1031-2.
3. Poiesz BJ, Ruscetti FW, Gadzar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci USA 1980; 77:7415-9.
4. Yoshida B, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T cell leukaemia and its implication in the disease. Proc Natl Acad Sci USA 1982;79:2031-5.
5. Mochizuki M, Watanabe T, Yamaguchi K. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992;83:236-9.
6. Terada K, Katamine S, Eguchi K, et al. Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet 1994;344:1116-9.
7. Nishioka K, Maruyama I, Sato K, Kitajama I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989;1:441.
8. Morgan O, Rodgers-Johnson P, Mora C, Char G. HTLV-I and polymyositis in Jamaica. Lancet 1989;2:1184-6.
9. Sugimoto M, Nakashima H, Watanabe S, et al. T lymphocyte alveolitis in HTLV-I associated myelopathy. Lancet 1987;2:1220.
10. Murphy EL, Hanchord B, Figueroa JP, et al. Modelling the risk of ATL in persons infected with HTLV-I. Int J Cancer 1989;43:250.
11. Kaplan JE, Osame M, Kubota H, et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquired Immune Defic Syndr 1990;3:1096-101.
12. Wayne Moore GR, Traugott U, Scheinberg LC, Raine CS. Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neural 1989;26: 523-30.
13. Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CDS+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990;348:245-8.
14. Lehky TJ, Fox CH, Koenig S, et al. Detection of human T-lymphotropic virus type I (HTLV-I) Tax RNA in the central nervous system of HTLV-I-associated myelopathy/ tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 1995;37:167-75.
15. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus type I. J Virol 1990;64:5682-7.
16. Paquette Y, Kay DG, Rassart E, Robitaille Y, Jolicœur P. Substitution of the U3 long terminal repeat region of the neurotropic Cas-Br-E retrovirus affects its disease-inducing potential. J Virol 1990;64:3742-52.
17. Rassart E, Paquette Y, Jolicœur P. Inability of kaplan radiation leukemia virus to replicate on mouse fibroblast is conferred by its long terminal repeat. J Virol 1988;62:3840-8.
18. Gonzalez-Dunia D, Grimber G, Briand P, Brahic M, Ozden S. Tissue expression pattern directed in transgenic mice by the LTR of an HTLV-I provirus isolated from a case of tropical spastic paraparesis. Virology 1992;187:705-10.
19. Evangelista A, Maroushek S, Minnigan H, et al. Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis. Microb Pathogen 1990;8: 259-78.
20. Coscoy L, Gonzalez-Dunia D, Chirinian-Syan S, Brahic M, Ozden S. Analysis of the expression directed by two HTLV-I promoters in transgenic mice. J Neuro Virol (in press).
21. Bieberich C, King C, Tinkle B, Jay G. A transgenic model of transactivation by the Tax protein of HTLV-I. Virology 1993;196:309-18.
22. Iizuka N, Kohara M, Hagino-Yamagishi K, et al. Construction of less neurovirulent polioviruses by introducing deletions into the 5′ noncoding sequence of the genome. J Virol 1989;63:5354-63.
23. Iwakura Y, Tosu M, Yoshida E, et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 1991;253:1026-8.
24. Vakil M, Kearney JF. In vivo suppression of perinatal multispecific B cells results in distortion of the adult B cell repertoire. Eur J Immunol 1986;16:1151.
25. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988;335:606-11.
26. Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G, Jay G. The tat gene of human T-lymphotropic virus type I induces mesenchymal tumors in transgenic mice. Science 1987;237:1324-9.
27. Hinrichs SH, Nerenberg M, Reynolds RK, Khoury G, Jay G. A transgenic mouse model for human neurofibromatosis. Science 1987;237:1340-3.
28. Green JE, Baird AM, Hinrichs SH, Klintworth GK, Jay G. Adrenal medullary tumors and iris proliferation in a transgenic mouse model of neurofibromatosis. Am J Pathol 1992; 140:1401-10.
29. Nerenberg MI, Minor T, Price J, Ernst DN, Shinohara T, Schwarz H. Transgenic thymocytes are refractory to transformation by the human T-cell leukemia virus type I tax gene. J Virol 1991;65:3349-53.
30. Benvenisty N, Ornitz DM, Bennett GL, et al. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/ c-myc and Ig/tax genes. Oncogene 1992;7:2399-405.
31. Grossman WJ, Kimata JT, Wong F-H, Zutter M, Ley TJ, Ratner L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1995;92:1057-61.
32. Iwakura Y, Tosu M, Yoshida E, et al. Augmentation of c-fos and c-jun expression in transgenic mice carrying the human T-cell leukemia virus type I tax gene. Virus Genes 1994;9 (2):161-70.
33. Yamada S, Ikeda H, Yamazaki H, et al. Cytokine-producing mammary carcinomas in transgenic rats carrying the pX gene of human T-lymphotropic virus type I. Cancer Res 1995;55:2524-7.
34. Furuta Y, Aizawa S, Suda Y, et al. Thymic atrophy characteristic in transgenic mice that harbor pX genes of human T-cell leukemia virus type I. J Virol 1989;63:3185-9.
35. Nerenberg MI, Wiley CA. Degeneration of oxidative muscle fibers in HTLV-I Tax transgenic mice. Am J Pathol 1989; 135:1025-33.
36. Ruddle NH, Li C-B, Home WC, et al. Mice transgenic for HTLV-I LTR-tax exhibit tax expression in bone, skeletal alterations, and high bone turnover. Virology 1993;197:196-204.
37. Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-I tax transgenic mice. Nature 1989;341:72-4.
38. Iwakura Y, Saijo S, Kioka Y, et al. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J Immunol 1995;155:1588-98.
39. Saggioro D, Rosato A, Esposito G, et al. Inflammatory polyarthritis and bone reabsorption in tax-transgenic mice. J Acq Immun Defic Syndromes Hum Retrovirol 1995;10:270.
40. Yamazaki H, Ikeda H, Ishizu A, et al. HTLV-I env-pX transgenic rats: prototype animal model for collagen vascular diseases. J Acq Immun Defic Syndromes Hum Retrovirol 1995;10:270.
41. Green JE, Begley G, Wagner DK, Waldmann TA, Jay G. trans activation of granulocyte-macrophage colonystimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type I tax gene. Mol Cell Biol 1989;9:4731-7.
42. Kim SJ, Kim SJ, Kehri JH, et al. Transactivation of the transforming growth factor β1 (TGF-β1) gene by human T lymphotropic virus type I tax: a potential mechanisms of the increased production of TGF-β1 in adult T cell leukemia. J Exp Med 1990;172:121-9.
43. Kim SJ, Winokur TS, Lee H-D, et al. Overexpression of transforming growth factor-β in transgenic mice carrying the human T-cell lymphotropic virus type I tax gene. Mol Cell Biol 1991;11:5222-8.
44. Xu X, Kang S-H, Heidenreich O, Okerholm M, O'Shea JJ, Nerenberg MI. Constitutive activation of different jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-I) tax protein or virus-transformed cells. J Clin Invest 1995;96: 1548-55.
45. Peebles RS, Maliszewski CR, Sato TA, et al. Abnormal B-cell function in HTLV-I-tax transgenic mice. Oncogene 1995;10:1045-51.
46. Kitajima I, Shinohara T, Minor T, Bibbs L, Bilakovics J, Nerenberg M. Human T-cell leukemia virus type I tax transformation is associated with increased uptake of oligode-oxynucleotides in vitro and in vivo. J Biol Chem 1992;267: 25881-8.
47. Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X, Nerenberg M. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kB. Science 1992;258:1792-5.
48. Bills ND, Hinrichs SH, Morgan R, Clifford AJ. Delayed tumor onset in transgenic mice fed a low-folate diet. J Natl Cancer Inst 1992;84:332-7.
49. Erlandson RA. Peripheral nerve sheath tumors. Ultrastruct Pathol 1985;9:113-22.